Schizophrenia Discover the archives of schizophrenia and related articles Depression, Schizophrenia 18 Oct, 2022 Read Time: 5 mins Article Strategies for precision prescribing in psychiatry In a symposium at CINP 2022 entitled ‘Strategies for Precision Prescribing in Psychiatry,’ Prof Siegfried... Mental Health 04 Oct, 2022 Read Time: 4 mins Congress highlights Article Benefits of measurement-based care in psychiatry Dr Erik Vanderlip (Oregon Health & Science University, USA) was involved in forming the Workgroup on... Schizophrenia 07 Sep, 2022 Read Time: 3 mins Congress highlights Article Interventions to improve real-life functioning Accurate assessment of neurocognition and social cognition and personalized cognitive training and... Schizophrenia 25 May, 2022 Read Time: 3 mins Congress highlights What is happening in the brain during schizophrenia? Neuroimaging reveals loss of brain gray matter volume in schizophrenia. New insights into the location and... Mental Health 03 Mar, 2022 Read Time: 3 mins Congress highlights Current practice with e-mental health and future standards E-mental health is the future for improved mental health delivery at all stages of the patient journey. It... Schizophrenia 18 Feb, 2022 Read Time: 3 mins Congress highlights Article New 2021 guidelines for the treatment of schizophrenia are now available in Japan The new evidence-based guidelines for the pharmacological therapy of schizophrenia from the Japanese... Schizophrenia 14 Feb, 2022 Read Time: 2 mins Congress highlights Can we predict the future of patients with early-episode psychosis? The ability to better predict patient outcomes would be highly valuable to clinicians, allowing the... Schizophrenia 08 Feb, 2022 Read Time: 4 mins Satellite symposium Long-acting therapies could reduce schizophrenia relapse Relapse in schizophrenia contributes to a downward spiral in disease progression. The likelihood of relapse... Schizophrenia 06 Dec, 2021 Read Time: 4 mins Satellite symposium The COVID-19 pandemic and mental health - impact and implications One of the goals of the European College of Neuropsychopharmacology (ECNP) is to facilitate the dialogue... Depression, Schizophrenia 02 Dec, 2021 Read Time: 5 mins Satellite symposium Exploring life engagement in major depressive disorder (MDD) and schizophrenia – mechanisms, measurement, and meaning Functional recovery is a key goal in treatment of major depressive disorder and schizophrenia. In an Otsuka... Mental Health 05 Nov, 2021 Read Time: 3 mins Congress highlights Highlights from ECNP 2021 — Day 1 — October 2nd Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College of... Mental Health 05 Nov, 2021 Read Time: 4 mins Congress highlights Highlights from ECNP 2021 — Day 2 — October 3rd Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College of... Mental Health 05 Nov, 2021 Read Time: 3 mins Congress highlights Highlights from ECNP 2021 — Day 3 — October 4th Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College of... Mental Health 05 Nov, 2021 Read Time: 3 mins Congress highlights Highlights from ECNP 2021 — Day 4 — October 5th Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College of... Bipolar, Schizophrenia 26 Oct, 2021 Read Time: 2 mins Congress highlights Do similar polygenic risk factors for schizophrenia apply across ethnic groups? Polygenic risk factors for schizophrenia and bipolar disorder-- and the genetic factors that distinguish... Schizophrenia 04 Oct, 2021 Read Time: 4 mins Satellite symposium Small steps for big impact in treatment of schizophrenia Functional recovery is an important goal in treating schizophrenia, but one that can be hard to achieve. At... Mental Health 02 Oct, 2021 Read Time: 3 mins Congress highlights Highlights from ECNP 2021 — Day 4 — October 5th Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College of... Schizophrenia 02 Oct, 2021 Read Time: 4 mins Satellite symposium Bridging treatment adherence to functional recovery in schizophrenia Non-adherence to treatment is a key issue in people with schizophrenia and can hold back response,... Schizophrenia 13 Sep, 2021 Read Time: 3 mins Congress highlights Cytokine dysregulation in schizophrenia Studies continue to indicate a multifaceted relationship between immunological and inflammatory processes... Mental Health 10 Aug, 2021 Read Time: 3 mins Congress highlights Pandemic requires comprehensive approach to mental health in the elderly Existing psychiatric problems such as depression and anxiety in the elderly should not be forgotten when... Schizophrenia 30 Jul, 2021 Read Time: 4 mins Congress highlights From clinic to community – insights on successful early psychosis management programs In the USA, OnTrackNY and the Early Psychosis Intervention NETwork (EPINET) are different parts of a... Schizophrenia 26 Jul, 2021 Read Time: 3 mins Congress highlights Patients at high risk for psychosis pose a clinical dilemma The concept of a clinical high risk syndrome for psychosis is justified not only by the fact that those who... Schizophrenia 26 Jul, 2021 Read Time: 3 mins Congress highlights Digital technology may support sustained long-term recovery in first episode psychosis Evolving technology can offer people with first episode psychosis personalized treatment when they need it,... Mental Health 26 Jul, 2021 Read Time: 3 mins Congress highlights Assess outcomes meaningful to patients to improve care equity and quality Ensuring that optimum healthcare is open to all - irrespective of gender, ethnicity and social and... Mental Health 26 Jul, 2021 Read Time: 3 mins Congress highlights Psychosis in dementia or dementia in psychosis? A clinical approach to a common puzzle Overlapping and interacting problems of late-life psychosis, depression and cognitive decline – including... Mental Health 26 Jul, 2021 Read Time: 3 mins Congress highlights The pandemic has permanently changed psychiatry, but perhaps not radically That was the slightly nuanced overall verdict from the debate. While 93% of the online audience agreed that... Schizophrenia 26 Jul, 2021 Read Time: 2 mins Congress highlights Rethinking ‘persistence’ in negative symptoms for better functional recovery Even short-term persistence of negative symptoms is associated with reduced clinical and real-life... Schizophrenia 19 Jul, 2021 Read Time: 2 mins Congress highlights To screen or not to screen in first-episode psychosis There is no international consensus on whether or not to submit those experiencing first-episode psychotic... Mental Health 14 Jul, 2021 Read Time: 2 mins Congress highlights Perspectives on the future of psychiatry: treatment and training Prevention, prediction of outcome and precision in therapy emerged as themes at the EPA 2021 symposium on... Schizophrenia 12 Jul, 2021 Read Time: 5 mins Congress highlights Intimacy, sexuality and psychosis – breaking the taboo Fact: Just likely everyone else, people with mental illness want to experience romance, love and intimacy.... Schizophrenia 30 Jun, 2021 Read Time: 4 mins Congress highlights Finding biotypes in psychosis – newer approaches It has been known for some time that factors such as longer duration of untreated illness are grossly... Schizophrenia 09 Jun, 2021 Read Time: 4 mins Congress highlights Psychosis during the COVID19 pandemic – who’s coping? The effects of the COVID19 pandemic have impacted everyone to a greater or lesser extent, often with... Schizophrenia 27 Jul, 2020 Read Time: 2 mins Congress highlights Expert guidance on management of schizophrenia for a better quality of life and independence Individualized patient management is key to achieving better lifetime quality of life and independence for... Schizophrenia 22 Jul, 2020 Read Time: 3 mins Article Digital technology in psychosis – it’s no delusion The application of digital interventions is starting to emerge as part of a rapidly expanding cache of... Mental Health 20 Jul, 2020 Read Time: 2 mins Congress highlights Digital lived-experience peer support—a major asset to achieving recovery goals Lived-experience peer support often leads to successful engagement of previously difficult-to engage... Schizophrenia 13 Jul, 2020 Read Time: 3 mins Article Double trouble - managing comorbidity in schizophrenia For healthcare workers, overcoming comorbidities in psychotic disorders is rarely straightforward as it is... Schizophrenia 09 Jul, 2020 Read Time: 3 mins Congress highlights Early intervention in first-episode psychosis: What works? There is a critical period when patients first experience symptoms of psychosis, which may present a window... Schizophrenia 08 Jul, 2020 Read Time: 3 mins Congress highlights Are antipsychotics needed for the long-term treatment of schizophrenia? ‘Do we need antipsychotics for the long-term treatment of schizophrenia?’ was the title of this important... Schizophrenia 24 May, 2020 Read Time: 1 min Interview Schizophrenia is a heterogeneous disease with multiple dimensions which can impact functioning Schizophrenia is a progressive and recurrent disease with multiple dimensions which can impact the overall... Schizophrenia 07 May, 2020 Read Time: 3 mins Article Making sense of exercise in schizophrenia - No sweat! Clinicians are well aware that cardiorespiratory fitness and cognition are related in schizophrenia.... Schizophrenia 29 Apr, 2020 Read Time: 3 mins Article Taper or maintain antipsychotics in schizophrenia? Taper or maintain? This is a central dilemma surrounding use of antipsychotic medication in patients with... Schizophrenia 16 Apr, 2020 Read Time: 3 mins Article Pandemic brings challenge and opportunity for people with schizophrenia The COVID-19 pandemic risks exacerbating symptoms in people prone to experience reality in unusual ways,... Mental Health 06 Apr, 2020 Read Time: 2 mins Article Practical support for mental health in time of crisis Many people with mental health diseases will experience additional emotional distress when faced with the... Schizophrenia 23 Mar, 2020 What is Schizophrenia? Depression, Schizophrenia 19 Mar, 2020 Read Time: 2 mins Interview Early intervention services have the potential to improve the success of treatment and social functioning for individuals with schizophrenia Schizophrenia is a heterogenous, progressive and recurrent disease with multiple dimensions which can... Schizophrenia 10 Mar, 2020 Improvement in schizophrenia: Long and short term perspectives Schizophrenia 27 Jan, 2020 Read Time: 3 mins Article The neurobiology of conversion to psychosis – emerging findings from the SHARP study The clinical high risk (CHR) phase of schizophrenia when cognitive and social functioning begin to decline... Schizophrenia 13 Jan, 2020 Read Time: 0 min Interview John FP Bridges - Changing the paradigm: putting patient treatment goals at the center Schizophrenia 08 Jan, 2020 Read Time: 0 min Interview John FP Bridges - Aiming for recovery: the world before Schizophrenia Schizophrenia 15 Oct, 2019 Read Time: 3 mins Satellite symposium Improving treatment outcomes in schizophrenia: Looking beyond positive symptoms for early and effective intervention Although the symptoms of schizophrenia are troublesome for almost all persons with the disease, its... Schizophrenia 12 Aug, 2019 Video #6: Which patients are best suited for long-acting injectable antipsychotics? Schizophrenia 11 Aug, 2019 Video #5: Early intervention in schizophrenia is key for the long-term prognosis of the disease Schizophrenia 10 Aug, 2019 Video #4: Discussing the benefit of long-acting injectable antipsychotics with patients and carers Depression, Schizophrenia 09 Aug, 2019 Video #3: Shared decision-making and therapeutic alliance in schizophrenia Schizophrenia 08 Aug, 2019 Video #2: Patients at the center Schizophrenia 07 Aug, 2019 Video #1: Offering long-acting injectable antipsychotics to patients with schizophrenia Schizophrenia 07 Jun, 2019 Read Time: 4 mins Congress highlights Early intervention for psychosis: Is it worth the investment? In a session at WFSBP, chaired by Professor Matcheri Keshavan, Harvard Medical School, Boston, MA, USA,... Schizophrenia, Alcohol Dependence 24 May, 2019 Read Time: 3 mins Congress highlights Decreasing relapse and rehospitalization in first-episode psychosis More than 50% of people with first-episode psychosis (FEP) have comorbid substance use disorder (SUD).1,2... Mental Health 21 May, 2019 Read Time: 3 mins Congress highlights What is the role of inflammation in the pathophysiology of mood disorders? Evidence supporting a role for inflammation and pro-inflammatory mediators in the pathophysiology and... Mental Health 21 May, 2019 Read Time: 3 mins Congress highlights A public invitation to view and comment on pre-final APA schizophrenia guideline statements Many guidelines exist worldwide on how best to manage psychiatric illnesses, but we never see two... Schizophrenia 16 May, 2019 Read Time: 4 mins Congress highlights Adherence in the real world Non-adherence and lack of engagement commonly mean that patients with serious mental illnesses may miss out... Mental Health 14 May, 2019 Read Time: 3 mins Congress highlights Challenges for social psychiatry in a changing world Modern social risk factors for the development of severe psychiatric disorders, such as migration and... Mental Health 09 May, 2019 Read Time: 4 mins Congress highlights Social isolation and stigma: Cross-cultural perspectives Meaningful connection to other people is as essential to health as the air we breathe. So the stigma that... Schizophrenia 02 May, 2019 Read Time: 3 mins Congress highlights Neuroimaging, antipsychotics and registries – functional capacity Neuroimaging studies of response to antipsychotic therapies and glutamate levels in first-episode psychosis... Schizophrenia 30 Apr, 2019 Read Time: 4 mins Congress highlights Enhancing neuroimaging genetics – What do we really see? Enhancing neuroimaging genetics through meta-analysis (ENIGMA) does exactly what its expanded acronym... Schizophrenia 15 Apr, 2019 Read Time: 5 mins Article Ethics of psychosis prevention – Could we? Should we? The SIRS Ethics Committee inaugurated the first of its annual symposia at SIRS 2019 to discuss the ethical... Schizophrenia 15 Apr, 2019 Read Time: 4 mins Article Deconstructing schizophrenia – constructing new paradigms for discovery Schizophrenia is a heterogeneous disorder rather than a specific condition, William Carpenter, University... Schizophrenia 15 Apr, 2019 Read Time: 3 mins Article Will the reconceptualization of negative symptoms lead to an effective therapy? A recent reconceptualization of the negative symptoms of schizophrenia promises to increase understanding... Mental Health 15 Apr, 2019 Read Time: 4 mins Congress highlights Psychiatrist and patient partnership encourages trust and effective care We have so many shared objectives – notably ensuring adequate resources are given to mental health – that... Schizophrenia 15 Apr, 2019 Read Time: 4 mins Article Early detection and intervention in psychosis – where are we now? Many of those experiencing first-episode psychosis achieve clinical remission, but often with poor... Schizophrenia 15 Apr, 2019 Read Time: 3 mins Article Biomarkers - the Future of Diagnosis in Psychiatry? Diagnosis of psychiatric disorders currently depends on clinical criteria. In the future the hope is that... Schizophrenia 03 Apr, 2019 Read Time: 4 mins Article Positive steps to address negative symptoms in schizophrenia A goal of precision psychiatry is to locate a patient along the continuum of the disease course, which may... Schizophrenia 01 Apr, 2019 Read Time: 2 mins Article Long-acting injectable or oral antipsychotic for first episode psychosis? Antipsychotic therapy improves outcomes for patients with first episode of psychosis, yet a study presented... Schizophrenia 06 Mar, 2019 Read Time: 4 mins Article The effects of antipsychotic dose reduction/discontinuation on long-term outcome in FEP patients Patients with FEP often ask whether they can discontinue their medication after a period of remission. This... Schizophrenia 27 Feb, 2019 Read Time: 3 mins Article Treatment-resistant schizophrenia — mechanisms, awareness, and economic burden One-third of individuals with schizophrenia develop treatment-resistant schizophrenia (TRS); and 70–84% of... Schizophrenia 21 Feb, 2019 Read Time: 5 mins Article Changing the course of schizophrenia: biology, psychology and livelihood How to manage and mitigate some long-term problems associated with schizophrenia, and improve functional... Schizophrenia 12 Feb, 2019 Read Time: 4 mins Article Complementary approaches for improving outcomes in first-episode psychosis Early intervention (EI) services are designed to improve outcomes in patients with first episode psychosis... Schizophrenia 07 Feb, 2019 Read Time: 1 min Article Early use of a long acting injectable antipsychotic shortens hospital stay for acute schizophrenia Average hospital stay for patients treated with a long-acting injectable (LAI) antipsychotic medication was... Schizophrenia 23 Jan, 2019 Read Time: 4 mins Article Use of fidelity scales to ensure and assess high-quality first episode psychosis services Fidelity scales ensure that services based on evidence deliver high-quality programs and outcomes, and... Mental Health 17 Jan, 2019 Read Time: 3 mins Article Real-world evidence — raising organizational fluency through interactive learning techniques Real-world evidence (RWE) demonstrates long-term effectiveness and safety beyond the efficacy and... Depression, Schizophrenia 09 Jan, 2019 Read Time: 3 mins Article Brain imaging: focus on predicting disease course and treatment response Predicting disease course and predicting response to therapy – including the probability that a person at... Depression, Schizophrenia 27 Dec, 2018 Read Time: 3 mins Article ICD-11: new and fit for clinical utility and consistency The new ICD chapter on mental health and behavioral disorders is designed to offer guidelines to clinical... Bipolar, Schizophrenia 19 Dec, 2018 Read Time: 3 mins Article Could therapeutic manipulation of critical periods of brain development benefit mental health? Many critical periods of brain development occur during infancy and childhood. When these periods are... Mental Health 17 Dec, 2018 Read Time: 3 mins Article Train, test, predict: Using big data and machine learning in psychiatry Introduction of biomarkers for diagnosis and treatment of psychiatric diseases into routine clinical... Bipolar, Schizophrenia 12 Dec, 2018 Read Time: 3 mins Article Brain connectivity in early psychosis and during effective antipsychotic therapy Resting state functional MRI of the brain is providing fascinating insights into the connectivity within... Bipolar, Schizophrenia 03 Dec, 2018 Read Time: 3 mins Article The OPUS Panel — Sharing lived experiences of mental illness A group of young people and their relatives (the OPUS Panel) aims to reduce societal prejudices and... Schizophrenia 28 Nov, 2018 Read Time: 4 mins Article Improving long-term outcomes in schizophrenia — translating evidence into practice The long-term goals of treatment to optimize outcomes for patients with schizophrenia are relapse... Depression, Schizophrenia 21 Nov, 2018 Read Time: 3 mins Article Inspiring efforts to improve mental health across countries and ages Mental ill-health in megacities was the theme for a presidential plenary session at 18th World Congress of... Mental Health 14 Nov, 2018 Read Time: 3 mins Congress highlights Transforming healthcare — the changing landscape of patient engagement Patient engagement is the facilitation and strengthening of the role of patients as co-producers of health... Mental Health 14 Nov, 2018 Read Time: 3 mins Congress highlights Early dialogues with patients are informing medicines development A 200-strong audience of health economics and outcomes research professionals at ISPOR 2018 overwhelmingly... Depression, Schizophrenia 12 Nov, 2018 Read Time: 3 mins Article The evolving science of psychiatry Science is beginning to reinforce the practice of psychiatry through increasing understanding of... Bipolar, Schizophrenia 01 Nov, 2018 Read Time: 3 mins Article Highlighted studies in psychosis New light cast on links between mental illness and creativity; inflammatory pathways that may be shared in... Schizophrenia 29 Oct, 2018 Read Time: 4 mins Article Future of schizophrenia treatment: Where do we go now? Over the next decade, the outcomes for patients with schizophrenia should improve considerably, explained... Schizophrenia 11 Oct, 2018 Read Time: 4 mins Congress highlights Tackling the elephant in the room: non-adherence in schizophrenia The challenges and consequences of non-adherence to treatment in schizophrenia, and some novel ways to... Depression, Schizophrenia 09 Oct, 2018 Read Time: 1 min Article What are you doing to celebrate World Mental Health Day? We asked advocacy groups from all around the world why it is important to support World Mental Health Day.... Schizophrenia 09 Oct, 2018 Read Time: 4 mins Congress highlights Dopamine D2 partial agonists – efficacy, tolerability and improved functioning? ‘Functioning’ is a broad term, and encompasses the individual’s ability to perform normal daily activities... Schizophrenia 27 Sep, 2018 Read Time: 3 mins Article Treatment-resistant schizophrenia – results of a survey on its clinical impact and therapeutic strategies The results of an online survey completed by 204 US psychiatrists on the clinical impact of... Schizophrenia 18 Sep, 2018 Read Time: 4 mins Article Schizophrenia – from prodrome to psychosis Psychosis is preceded by a 3–4 year prodromal phase in 75% of patients, but only 25% of clinical high-risk... Depression, Schizophrenia 10 Sep, 2018 Read Time: 1 min Interview How can you support carers for people with schizophrenia and psychosis? More than 25.000 carers have already signed up to The Carer Academy, an interactive online course and forum... Schizophrenia 01 Aug, 2018 Read Time: 3 mins Article Steps towards more effective and better tolerated treatment options for schizophrenia New more effective and better tolerated treatments for schizophrenia are needed to improve patient outcomes... Schizophrenia 11 Jun, 2018 Read Time: 3 mins Article Effective treatment of schizophrenia requires a patient-centered approach Recognition of how people with schizophrenia interact and cope with their experiences is necessary for... Schizophrenia 08 May, 2018 Read Time: 4 mins Congress highlights If one antipsychotic is good, why aren’t two better? Polypharmacy debated Increased risk of side effects, reduced compliance, lack of rationale and, above all, no evidence of... Schizophrenia 22 Feb, 2018 Read Time: 3 mins Article Bouncing back - Resilience in schizophrenia Can we improve resilience in patients with schizophrenia to help recovery? Resilience is increasingly being... Schizophrenia 09 Jan, 2018 Read Time: 3 mins Feature Right treatment at right time: Improving outcomes in first episode psychosis Integrating evidence-based psychosocial and pharmacological treatments significantly improves the quality... Bipolar, Schizophrenia 02 Nov, 2017 Read Time: 4 mins Article Exploring brain connectivity in schizophrenia There has been an explosion of interest in research on brain connectivity, across disorders in psychiatry.... Depression, Schizophrenia 13 Sep, 2017 Read Time: 3 mins Congress highlights Sexual side-effects – let’s talk! Sexual side-effects, sometimes experienced by patients during treatment, are not only debilitating but may... Schizophrenia 04 Sep, 2017 Read Time: 6 mins Satellite symposium Preventing schizophrenia relapse key to optimizing outcome Sustained remission and good functional outcome depend on the interaction between factors we cannot control... Schizophrenia 23 May, 2017 Read Time: 1 min Event World Schizophrenia Day 2017 EUFAMI speaks about the importance of patient access to treatments that improve Quality of Life and... Mental Health 07 Mar, 2017 Read Time: 8 mins Feature Genetic and Environmental Impact on Psychiatric and Neurological Disease Schizophrenia 06 Jul, 2016 Read Time: 0 min Slide library Epidemiology and Burden Schizophrenia 01 Jun, 2016 Read Time: 4 mins Feature Schizophrenia across cultures Most Popular
